Annual ROE
-101.46%
+45.06%+30.75%
31 December 2023
Summary:
OncoCyte annual return on equity is currently -101.46%, with the most recent change of +45.06% (+30.75%) on 31 December 2023. During the last 3 years, it has fallen by -8.39% (-9.01%). OCX annual ROE is now -121.85% below its all-time high of 464.25%, reached on 31 December 2014.OCX ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly ROE
-211.42%
-78.48%-59.03%
30 September 2024
Summary:
OncoCyte quarterly return on equity is currently -211.42%, with the most recent change of -78.48% (-59.03%) on 30 September 2024. Over the past year, it has dropped by -88.14% (-71.50%). OCX quarterly ROE is now -152.97% below its all-time high of 399.16%, reached on 30 June 2015.OCX Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
OCX ROE Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +30.8% | -71.5% |
| 3 y3 years | -9.0% | -361.5% |
| 5 y5 years | +78.0% | -191.0% |
OCX ROE High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -9.0% | +30.8% | -361.5% | at low |
| 5 y | 5 years | -39.5% | +78.0% | -387.4% | at low |
| alltime | all time | -121.8% | +78.0% | -153.0% | +26.7% |
OncoCyte ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | -211.42%(+59.0%) |
| June 2024 | - | -132.94%(+0.6%) |
| Mar 2024 | - | -132.13%(+65.4%) |
| Dec 2023 | -101.46%(-30.8%) | -79.90%(-35.2%) |
| Sept 2023 | - | -123.28%(+16.1%) |
| June 2023 | - | -106.15%(+4.8%) |
| Mar 2023 | - | -101.27%(-10.7%) |
| Dec 2022 | -146.52%(+12.8%) | -113.40%(+37.4%) |
| Sept 2022 | - | -82.55%(-0.3%) |
| June 2022 | - | -82.80%(+1.2%) |
| Mar 2022 | - | -81.78%(+3.9%) |
| Dec 2021 | -129.88%(+39.6%) | -78.68%(+71.8%) |
| Sept 2021 | - | -45.81%(+5.6%) |
| June 2021 | - | -43.38%(-16.6%) |
| Mar 2021 | - | -52.04%(-39.1%) |
| Dec 2020 | -93.07%(+28.0%) | -85.43%(-4.2%) |
| Sept 2020 | - | -89.14%(+1.2%) |
| June 2020 | - | -88.04%(+9.1%) |
| Mar 2020 | - | -80.72%(+18.7%) |
| Dec 2019 | -72.72% | -68.03%(-6.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2019 | - | -72.65%(-10.2%) |
| June 2019 | - | -80.92%(-28.5%) |
| Mar 2019 | - | -113.18%(-51.8%) |
| Dec 2018 | -460.24%(+4.6%) | -235.00%(+7.3%) |
| Sept 2018 | - | -218.95%(-19.1%) |
| June 2018 | - | -270.48%(-0.6%) |
| Mar 2018 | - | -272.17%(-5.7%) |
| Dec 2017 | -440.04%(+288.6%) | -288.49%(+25.9%) |
| Sept 2017 | - | -229.16%(+49.0%) |
| June 2017 | - | -153.77%(+6.3%) |
| Mar 2017 | - | -144.71%(+9.8%) |
| Dec 2016 | -113.24%(+35.1%) | -131.77%(-2.2%) |
| Sept 2016 | - | -134.71%(-9.5%) |
| June 2016 | - | -148.77%(+26.5%) |
| Mar 2016 | - | -117.63%(+30.4%) |
| Dec 2015 | -83.85%(-118.1%) | -90.24%(-47.0%) |
| Sept 2015 | - | -170.39%(-142.7%) |
| June 2015 | - | 399.16%(+49.1%) |
| Mar 2015 | - | 267.78%(+90.8%) |
| Dec 2014 | 464.25%(-580.2%) | 140.32% |
| Dec 2013 | -96.68% | - |
FAQ
- What is OncoCyte annual return on equity?
- What is the all time high annual ROE for OncoCyte?
- What is OncoCyte annual ROE year-on-year change?
- What is OncoCyte quarterly return on equity?
- What is the all time high quarterly ROE for OncoCyte?
- What is OncoCyte quarterly ROE year-on-year change?
What is OncoCyte annual return on equity?
The current annual ROE of OCX is -101.46%
What is the all time high annual ROE for OncoCyte?
OncoCyte all-time high annual return on equity is 464.25%
What is OncoCyte annual ROE year-on-year change?
Over the past year, OCX annual return on equity has changed by +45.06% (+30.75%)
What is OncoCyte quarterly return on equity?
The current quarterly ROE of OCX is -211.42%
What is the all time high quarterly ROE for OncoCyte?
OncoCyte all-time high quarterly return on equity is 399.16%
What is OncoCyte quarterly ROE year-on-year change?
Over the past year, OCX quarterly return on equity has changed by -88.14% (-71.50%)